Glycocalyx and its involvement in clinical pathophysiologies
- PMID: 27617097
- PMCID: PMC5017018
- DOI: 10.1186/s40560-016-0182-z
Glycocalyx and its involvement in clinical pathophysiologies
Abstract
Vascular hyperpermeability is a frequent intractable feature involved in a wide range of diseases in the intensive care unit. The glycocalyx (GCX) seemingly plays a key role to control vascular permeability. The GCX has attracted the attention of clinicians working on vascular permeability involving angiopathies, and several clinical approaches to examine the involvement of the GCX have been attempted. The GCX is a major constituent of the endothelial surface layer (ESL), which covers most of the surface of the endothelial cells and reduces the access of cellular and macromolecular components of the blood to the surface of the endothelium. It has become evident that this structure is not just a barrier for vascular permeability but contributes to various functions including signal sensing and transmission to the endothelium. Because GCX is a highly fragile and unstable layer, the image had been only obtained by conventional transmission electron microscopy. Recently, advanced microscopy techniques have enabled direct visualization of the GCX in vivo, most of which use fluorescent-labeled lectins that bind to specific disaccharide moieties of glycosaminoglycan (GAG) chains. Fluorescent-labeled solutes also enabled to demonstrate vascular leakage under the in vivo microscope. Thus, functional analysis of GCX is advancing. A biomarker of GCX degradation has been clinically applied as a marker of vascular damage caused by surgery. Fragments of the GCX, such as syndecan-1 and/or hyaluronan (HA), have been examined, and their validity is now being examined. It is expected that GCX fragments can be a reliable diagnostic or prognostic indicator in various pathological conditions. Since GCX degradation is strongly correlated with disease progression, pharmacological intervention to prevent GCX degradation has been widely considered. HA and other GAGs are candidates to repair GCX; further studies are needed to establish pharmacological intervention. Recent advancement of GCX research has demonstrated that vascular permeability is not regulated by simple Starling's law. Biological regulation of vascular permeability by GCX opens the way to develop medical intervention to control vascular permeability in critical care patients.
Keywords: Endothelial surface layer; Glycocalyx; Heparan sulfate; Hyaluronan; Lectin; Leukocyte; Sepsis; Starling’s law; Syndecan-1; Vascular permeability.
Figures
Similar articles
-
Structural Behavior of the Endothelial Glycocalyx Is Associated With Pathophysiologic Status in Septic Mice: An Integrated Approach to Analyzing the Behavior and Function of the Glycocalyx Using Both Electron and Fluorescence Intravital Microscopy.Anesth Analg. 2017 Sep;125(3):874-883. doi: 10.1213/ANE.0000000000002057. Anesth Analg. 2017. PMID: 28504989
-
Fluorescent imaging of endothelial glycocalyx layer with wheat germ agglutinin using intravital microscopy.Microsc Res Tech. 2016 Jan;79(1):31-7. doi: 10.1002/jemt.22602. Epub 2015 Nov 19. Microsc Res Tech. 2016. PMID: 26768789
-
Exploring the mechanism of hyperpermeability following glycocalyx degradation: Beyond the glycocalyx as a structural barrier.PLoS One. 2021 Jun 4;16(6):e0252416. doi: 10.1371/journal.pone.0252416. eCollection 2021. PLoS One. 2021. PMID: 34086745 Free PMC article.
-
Endothelial barrier reinforcement relies on flow-regulated glycocalyx, a potential therapeutic target.Biorheology. 2019;56(2-3):131-149. doi: 10.3233/BIR-180205. Biorheology. 2019. PMID: 30988234 Free PMC article. Review.
-
Glycocalyx in Atherosclerosis-Relevant Endothelium Function and as a Therapeutic Target.Curr Atheroscler Rep. 2017 Nov 10;19(12):63. doi: 10.1007/s11883-017-0691-9. Curr Atheroscler Rep. 2017. PMID: 29127504 Free PMC article. Review.
Cited by
-
Capillary leak and endothelial permeability in critically ill patients: a current overview.Intensive Care Med Exp. 2023 Dec 20;11(1):96. doi: 10.1186/s40635-023-00582-8. Intensive Care Med Exp. 2023. PMID: 38117435 Free PMC article. Review.
-
Chronic cranial window implantation for high-resolution intravital imaging of the endothelial glycocalyx in mouse cortex.STAR Protoc. 2023 Dec 15;4(4):102712. doi: 10.1016/j.xpro.2023.102712. Epub 2023 Nov 17. STAR Protoc. 2023. PMID: 37967013 Free PMC article.
-
Changes in the levels of free sialic acid during ex vivo lung perfusion do not correlate with pulmonary function. Experimental model.BMC Pulm Med. 2023 Sep 4;23(1):326. doi: 10.1186/s12890-023-02619-w. BMC Pulm Med. 2023. PMID: 37667267 Free PMC article.
-
HYAL1 deficiency attenuates lipopolysaccharide-triggered renal injury and endothelial glycocalyx breakdown in septic AKI in mice.Ren Fail. 2023 Dec;45(1):2188966. doi: 10.1080/0886022X.2023.2188966. Ren Fail. 2023. PMID: 37563795 Free PMC article.
-
Fast-track preparation of lung specimens for electron microscope observations of the pulmonary endothelial glycocalyx.Med Mol Morphol. 2023 Dec;56(4):239-249. doi: 10.1007/s00795-023-00360-1. Epub 2023 Jul 5. Med Mol Morphol. 2023. PMID: 37405470
References
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
